EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam after Switching from Generic Antiseizure Drug
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.472
https://www.valueinhealthjournal.com/article/S1098-3015(22)00673-8/fulltext
Title :
EE224 Comparative Economic Outcomes in Patients with Focal Seizure Initiating Eslicarbazepine Acetate Versus Brivaracetam after Switching from Generic Antiseizure Drug
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00673-8&doi=10.1016/j.jval.2022.04.472
First page :
Section Title :
Open access? :
No
Section Order :
10417